Diabetes Flashcards

1
Q

Diagnosis of DMII made on…?

A

HbA1c > 48mmol/mol
Random plasma Glucose > 11.1mmol/mol
Fasting plasma glucose > 7mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors affecting HbA1c?

A
Haemolysis (low)
Iron deficiency anaemia
Renal impairment
Pregnancy
Blood transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pre-diabetes HbA1c?

A

43-48mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HbA1c treatment target for patients taking hypoglycaemic-associated drugs?

A

53mmol/mol

Hypo-associated drugs eg sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Initial diabetic drug treatment?

A

Metformin, titrated up to reduce risk of adverse GI effects

MONITOR RENAL FUNCTION BEFORE AND AFTER STARTING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug treatment after metformin or if contraindicated?

A

1 - gliptin (DPP-4)
2 - pioglitazone
3 - sulfonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When to add insulin?

A

Consider when ineffective double/triple therapy (metformin + other x2),
(Or if other drugs are contraindicated/not tolerated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metformin MOA

A
Metformin is a biguanide
(Acts on AMPK)
Decrease hepatic gluconeogenesis
Increase insulin sensitivity
Increase peripheral glucose uptake
Decrease gut absorption of glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sulfonylureas MOA

A

Bind to pancreatic receptors

Increase insulin production (hence hypo risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pioglitazone MOA

A

Pioglitazone is a thiazolidinedione
(Acts on PPAR alpha and gamma)
Increase insulin sensitivity in lots of tissues
Decrease visceral fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GLP-1 (Incretin) MOA

A

Glucagon-like-peptide mimetic
Causes insulin secretion
(minor hypo risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gliptin MOA

A

DPP-4 inhibitor

Prevents inactivation of endogenous GLP-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sulfonylurea contraindications/cautions

A

Contra: acute porphyria
Cautions: renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metformin contraindications/cautions

A

Contra: ketoacidosis
Cautions: avoid in severe renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pioglitazone contraindications/cautions

A

Contra: Heart failure; bladder cancer
Cautions: monitor liver function, avoid if impairment/disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gliptin contraindications/cautions

A

Caution: Pancreatitis

17
Q

DKA scenario - first line management?

A

Initial fluid resuscitation with normal saline

18
Q

DKA scenario - hyperkalaemic…principles of treating?

A

Serum K+ maybe high as insulin normally drives K+ into cells. But overall K+ is probably low (due to fluid loss), and needs careful replacement therapy and monitoring.

19
Q

Metformin adverse effects

A
  • GI: nausea, diarrhoea, bloating
  • Metallic taste
  • Lactic acidosis
20
Q

Gliptin adverse effects

A
  • GI disturbances
  • Nasopharyngitis, URTI
  • Peripheral oedema

NB - Pancreatitis

21
Q

Pioglitazone adverse effects

A
  • Fluid retention
  • Weight gain
  • Anaemia
  • Arthralgia
  • GI disturbances
22
Q

Sulfonylurea adverse effects

A

Hypoglycaemia!

Others are mild and infrequent
GI disturbances
Hypersensitivity

23
Q

GLP-1 mimetic adverse effects?

A
Acute pancreatitis (rare but serious)
GI disturbances (lots)
Hypoglycaemia
GORD
Dizziness
24
Q

Sulfonylurea examples?

A

Glibenclamide
Gliclazide
Tolbutamide

25
Q

DPP-4 inhibitor examples?

A

Gliptins eg:
Linagliptin
Sitagliptin

26
Q

GLP-1 examples?

A

Liraglutide

Exenatide

27
Q

SGLT-2i examples?

A

Canagliflozin

Dapagliflozin